Sigma Planning Corp’s CareDx CDNA Stock Holding History

Sigma Planning Corp’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-16,500	Closed	-$520K	–	1003
2019 Q1	$520K	Buy	+16,500	New	+$481K	0.03%	502

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sigma Planning Corp's CDNA Position: Q2 2019 in Review

Sigma Planning Corp sold out of CareDx (CDNA) in Q2 2019, closing a stake of 16,500 shares — an estimated $520K sold.

Sigma Planning Corp first reported a position in CDNA in Q1 2019 and held it in 1 quarter. The position peaked at $520K in Q1 2019. 182 funds tracked by Wall St. Rank hold CDNA as of Q2 2019.

Sigma Planning Corp reported no remaining CareDx position as of Q2 2019 after selling out during the quarter.
Sigma Planning Corp sold 16,500 CareDx shares in Q2 2019, an estimated $520K.
Sigma Planning Corp first reported a position in CareDx in Q1 2019 and held it in 1 quarter.
Sigma Planning Corp's CareDx position peaked at $520K in Q1 2019.
182 funds tracked by Wall St. Rank held CareDx as of Q2 2019.

Based on Sigma Planning Corp's 13F filing for Q2 2019, filed 1 Aug 2019.